ISCT (International Society for Cell & Gene Therapy)

Stand: 2203
Conference Website

Date: 6–9 May 2026

Location: Convention Centre Dublin, Ireland

eXmoor Pharma will be exhibiting at the ISCT Annual Meeting, bringing together the global cell and gene therapy community to focus on translation, clinical delivery and manufacturing strategy.

Meet the team

You can find eXmoor Pharma on stand 2203. Members of our team attending include:

Lucy Foley, CEO
Manel Balbuena, Chief Commercial Officer
Carol Elvira, Business Development Manager
Ruxandra Comisel, Business Development Manager
Kate Fynes, CMC Consultant

Our team will be available throughout the event to connect with developers progressing cell and gene therapy programmes from research through to clinical manufacturing.

Panels

Kate Fynes will be speaking at the following session:

“Enabling Standardization and Scale-up in Treg and other Next Generation Cell Therapies“
SONY Corporate Session
Wednesday 6 May 2026 | 12:00–13:00

This session will explore approaches to improving consistency, scalability and clinical readiness in next-generation cell therapies, including Tregs and other immune cell-based modalities. Topics include standardisation of cell processing workflows, high-purity cell selection, and strategies to support transition from process development into clinical and commercial manufacturing.

Why meet us at ISCT?

ISCT brings together teams working at the point where scientific innovation meets clinical and manufacturing reality. We work with developers to:

• Plan and deliver technology transfer into GMP manufacturing environments
• Translate early-stage science into processes that are suitable for GMP
• Build process and analytical understanding to support clinical progression

Arrange a meeting

If you are attending ISCT and would like to meet a member of the eXmoor Pharma team, you are welcome to connect via the event app or on LinkedIn to arrange a conversation during the event.